The impact of diabetes mellitus and microvascular complications on heart failure biomarkers

25 May 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Florina Fringu

University of Medicine and Pharmacy of Cluj Napoca, Cluj Napoca (Romania)

24 More presentations in this session

Presentation thumbnail

Evaluation of the effectiveness of lisinicore and losartan in patients with chronic heart failure

Professor U. Kamilova (Tashkent, UZ)

Abstract Slides

Presentation thumbnail

Profile and follow up of the elderly patient with heart failure

Doctor D. Enriquez Vazquez (A Coruna, ES)

Presentation thumbnail

Impaired filtration and tubular kidney functions in patients with chronic heart failure with a moderately reduced left ventricular ejection fraction and persistent atrial fibrillation

Professor N. Koziolova (Perm, RU)

Presentation thumbnail

What is the difference in clinical, instrumental characteristics and prognosis in patients with CHF and rLVEF in regard to the presence and nature of the iron deficiency state?

Doctor V. Gorbachova (Aarau, CH)

Presentation thumbnail

Left ventricular systolic dysfunction in asymptomatic patients with diabetes mellitus type 1 is associated with duration of disease, obesity and poor glycemic control

Doctor C. Kapelios (Athens, GR)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 3 - Chronic Heart Failure - Clinical

The Event

Heart Failure 2019

25 May - 28 May 2019

You may be interested in

Congress Presentation

Cardio-Kidney-metabolic overlap in HFpEF: cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HF

Congress Session

Chronic kidney disease and heart failure

Congress Presentation

Impact of multimorbidity on mortality in heart failure with mildly reduced and preserved ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources